Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference 12/23/19 Eagle Pharmaceuticals Granted Orphan Drug Designation for RYANODEX (dantrolene sodium) for Treatment of Organophosphate Exposure (Nerve Agents) 12/16/19 Eagle Pharmaceuticals Reaches Settlement Agreement with Eli Lilly for PEMFEXY (pemetrexed for injection) 12/13/19 Eagle Pharmaceuticals Commences Dosing in Pilot Study for Novel Estrogen Receptor Antagonist Product Candidate 12/9/19 Eagle Pharmaceuticals to Present at 31st Annual Piper Jaffray Healthcare Conference 11/20/19 Eagle Pharmaceuticals Announces Departure of Douglas L. Braunstein from Board of Directors 11/14/19 Eagle Pharmaceuticals Reports Third Quarter 2019 Results 11/12/19 Eagle Pharmaceuticals Announces Enrollment of Additional Exertional Heat Stroke Patients at the 2019 Hajj Pilgrimage 11/12/19 Eagle Pharmaceuticals to Discuss Third Quarter 2019 Financial Results on November 12, 2019 10/31/19 Eagle Pharmaceuticals’ Japanese Licensing Partner SymBio Announces its Submission of a New Drug Application for TREAKISYM® Ready-To-Dilute Formulation 10/7/19 Pagination Current page 1 Page 2 Page 3 Next page Last page